Monongahela Valley Hospital has signed a definitive agreement to affiliate with Penn Highlands Healthcare
|Deal Type||Mergers & Acquisitions|
|Client & Transactional Partners||
Monongahela Valley Hospital
Penn Highlands Healthcare
|Our Role||Sell-Side Advisor|
Monongahela Valley Hospital, a non-for-profit community hospital providing top quality care to patients in their communities south of Pittsburgh, has signed a Definitive Agreement to merge with Penn Highlands Healthcare.
Cain Brothers, a division of KeyBanc Capital Markets, served as exclusive financial advisor to MVH, highlighting Cain Brothers’ deep domain expertise and strong relationships in the hospital and health system sector.
The affiliation will enable MVH to continue providing high-quality care to its patients while expanding its services. Penn Highlands will have an opportunity to grow its footprint across the region and to expand to the southwestern part of the state. The affiliation is expected to close in the fall of 2021 and is designed to strengthen the delivery of healthcare services in the community.
MVH is a 200-bed facility with a 225-member medical staff representing more than 40 specialties. The hospital has a leading market position approximately 25 miles south of Pittsburgh and a reputation for continually introducing the latest technology in cancer care diagnosis and treatment, orthopedics, wound care and diagnostic radiology. MVH is the largest employer in the mid-Monongahela Valley with more than 1,200 employees, making it a vital piece of the region’s economy.
Penn Highlands was formed in 2011 and is comprised of six acute care hospitals, a home care agency, two long-term care facilities and a senior residential living facility. The facilities have a total of 815 inpatient and skilled nursing beds. Penn Highlands has 525 physicians and 281 advanced practice providers on staff. The system offers a wide range of care and treatments with specialty units that care for cancer, cardiovascular/thoracic, neurosurgery, pulmonology, neonatal and high-risk pregnancy patients.